Open access
Sep 2026
Prevalence of germline BRCA1/2 mutations in breast and ovarian cancer patients: A study in a reference laboratory
A prevalence of 19.3% is revealed for germline BRCA1/2 mutations in the tested population, with BRCA1 p.(Ser1379Ter) emerging as a recurrent variant, warranting further investigation as a possible founder mutation.
Samah N. Saharti
· Journal of King Saud Univers... · 0 citations